Assessment of the impact of FcγRIIIA single-nucleotide polymorphisms on the efficacy of IgG1 monoclonal antibodies in patients with advanced gastroesophageal adenocarcinoma von Serritella, A.V., Grewal, N.K.S., Peterson, B., Arndt, K., Gaudio, D.D., Liu, P., Shergill, A., Polite, B., Kindler, H.L., Catenacci, D.V.T., Liao, C.Y.

Volltext